Pharmacovigilance Risk Assessment Committee (PRAC) has initiated the implementation of temporary precautionary measures while reviewing Esmya
2/9/2018
Business related Regulatory Women's Healthcare PRODUCT - ESMYA API - ULIPRISTAL ACETATE